The architecture integrated care.
German Roots. Swiss Precision. Global Vision.
The MediFirst Group is the roof of a vertically integrated ecosystem. We connect specification, research, pharmaceutical operations, and care into a closed system of responsibility.
No fragmented responsibilities. Clear roles, defined interfaces, documented standards.
This makes scientific potential supply-ready as a process - reproducible, scalable, and traceable
MediFirst integrates the value chain where supply needs reliability: from defined specification through GxP-compliant realization to controlled distribution - with feedback into quality and development logic.
Group structure: specialization as a system advantage
Within the MediFirst Group, highly specialized units work hand in hand. Each unit carries a clearly delineated part of the responsibility, and each interface strengthens system quality This reduces friction losses at handovers and creates a learning system: Insights from care practice flow back in a structured way into our quality and development logic:
Strategie & Governance – MediFirst Invest
The group’s strategic holding company. Responsible for capital allocation, investment management, and long-term infrastructure and site development.
Swiss Axis - Grow Art AG & Innuana AG
Origin, standards, and translation. This is where quality begins with specification - as the foundation for reproducible pharmaceutical processes and robust development logic.
Scientific Hub - MediFirst Biotech / MediFirst R&D
Validation and development. We consistently align our work with care-relevant questions and operate along internationally established research standards.
Pharmaceutical Operations - MediFirst Pharma
Realization and market access. As the pharmaceutical entrepreneur, we take responsibility for placing on the market, GxP-compliant quality assurance, and specialized distribution within the EU.
Infrastructure & Trade - MediFirst Commerce & MediFirst Supply (in formation)
Market access and availability. We steer B2B structures, partner logistics, and operational rollout capability along defined standards.
Care - MediFirst Medicum GmbH (in formation) (Medical Care Center in Dresden, opening 2027)
Interface to care practice. Structured workflows and measurable routines form the basis for continuous improvement - and for refining standards and care concepts.
Sovereignty through integration.
In a market environment that demands professionalization, we offer a system without breaks. We use our Swiss precision Swiss precision for specification, our German hubs for realization, and our Medical Care Center (opening 2027) for validation.
The result is care sovereignty that elevates the previously professionally underrepresented area of specialized therapies (with a focus on cannabinoids) to the level of a robust medical standard.
Contact
Do you have questions or concerns? We are here for you.
Note: MediFirst Pharma and the MediFirst Group do not answer individual medical questions and do not provide personal therapy recommendations.
